Moon Surgical today announced its Maestro surgical robot is being used clinically in gynecological laparoscopic procedures.
The Paris-based company’s surgical robot has routinely been used by eight surgeons in two facilities in France across 20 different clinical indications, including abdominal and bariatric. The recent gynecological use was for hysterectomy, cystectomy, adnexectomy and ovariectomy procedures.
Related: Elekta and MSD team up for digital kidney cancer care
Surgeons completed the new procedures following the same onsite, one-hour-long training curriculum as previous surgical cases with the Maestro surgical robot.
“Performing gynecological procedures using the Maestro was natural,” said Dr. Chehab, an OB/GYN at the Franche-Comté Polyclinic in Besançon, France, part of the Elsan private hospitals network. “I could use the same instruments I operate with every day and docking them was very simple. I was even able to have the Maestro hold the uterine manipulator, which is typically done by my assistant holding a particularly uncomfortable pose.”
Moon Surgical announced the first commercial Maestro surgical robot cases in France in October last year following its first U.S. clinical cases.
Moon Surgical designed Maestro to provide an accessible, enhanced version of traditional laparoscopy. Maestro acts as a robotic surgical assistant to augment the precision and control of laparoscopic surgery. The small, adaptable system can integrate into existing clinical workflows. It features capabilities that bolster operating room efficiency and allow for alternative labor models.
Maestro’s extra set of arms offers surgeons control of two additional instruments. Moon Surgical says it provides optimal vision and tissue access throughout the procedure.
“Maestro’s adaptability was already demonstrated in the field of digestive surgery, where the system has been used for pretty much any indication successfully. Expanding our experience to gynecology is an exciting step towards our goal of providing unprecedented surgical assistance to soft tissue surgical teams everywhere,” CEO Anne Osdoit said.
